Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Inventory Average: 2021-2025

Historic Inventory Average for Xeris Biopharma Holdings (XERS) over the last 4 years, with Sep 2025 value amounting to $67.4 million.

  • Xeris Biopharma Holdings' Inventory Average rose 52.95% to $67.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.4 million, marking a year-over-year increase of 52.95%. This contributed to the annual value of $43.5 million for FY2024, which is 36.87% up from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Inventory Average stood at $67.4 million for Q3 2025, which was up 12.31% from $60.0 million recorded in Q2 2025.
  • Xeris Biopharma Holdings' Inventory Average's 5-year high stood at $67.4 million during Q3 2025, with a 5-year trough of $16.2 million in Q4 2021.
  • For the 3-year period, Xeris Biopharma Holdings' Inventory Average averaged around $44.2 million, with its median value being $41.9 million (2024).
  • Data for Xeris Biopharma Holdings' Inventory Average shows a peak YoY surged of 96.49% (in 2023) over the last 5 years.
  • Xeris Biopharma Holdings' Inventory Average (Quarterly) stood at $16.2 million in 2021, then skyrocketed by 38.62% to $22.4 million in 2022, then spiked by 71.62% to $38.5 million in 2023, then grew by 21.19% to $46.6 million in 2024, then spiked by 52.95% to $67.4 million in 2025.
  • Its Inventory Average stands at $67.4 million for Q3 2025, versus $60.0 million for Q2 2025 and $50.4 million for Q1 2025.